Molecular Characterization of Staphylococcus aureus Isolates From Children With Periorbital or Orbital Cellulitis.

Authors:
Catherine E Foster
Catherine E Foster
Baylor College of Medicine and Texas Children's Hospital Catherine.Foster@bcm.edu
Elizabeth Yarotsky
Elizabeth Yarotsky
M.D. Anderson Cancer Center
Edward O Mason
Edward O Mason
Baylor College of Medicine
United States
Sheldon L Kaplan
Sheldon L Kaplan
Baylor College of Medicine
United States
Kristina G Hulten
Kristina G Hulten
Baylor College of Medicine
United States

J Pediatric Infect Dis Soc 2018 Aug;7(3):205-209

Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston.

Background: Periorbital and orbital cellulitis cause significant pediatric morbidity. Here, we define the clinical features of and characterize isolates from children with periorbital or orbital cellulitis caused by Staphylococcus aureus at Texas Children's Hospital in Houston.

Methods: Patients were identified from a prospective S aureus study database from January 2002 to July 2015. Demographic and clinical data were collected retrospectively. Isolates were genotyped by pulsed-field gel electrophoresis, and Panton-Valentine leukocidin (lukSF-PV [pvl]) genes were detected by quantitative polymerase chain reaction. Data were analyzed with the Fisher exact or Wilcoxon rank-sum test.

Results: Eighty-five patients with periorbital (n = 58) or orbital (n = 27) cellulitis were identified. We found 57 (67%) methicillin-resistant S aureus (MRSA) isolates, 72 (85%) pvl-positive (pvl+) isolates, and 66 (78%) USA300 isolates. No differences in clinical characteristics were found when we compared MRSA to methicillin-susceptible (MSSA) infections or USA300 to non-USA300 infections. Patients with orbital cellulitis were hospitalized a median of 12 days (range, 2-28 days) and received antibiotics for 21 days (range, 10-32 days). Twelve (44%) patients with orbital cellulitis received steroids. Steroid treatment did not affect the length of hospitalization or duration of antibiotic treatment. Six (7%) patients with orbital cellulitis were bacteremic. Patients with periorbital cellulitis were hospitalized for a median of 3 days (range, 0-17 days) and received antibiotics for 11 days (range, 7-32 days). According to computed tomography (CT), 19 (70%) patients with orbital cellulitis and 11 (41%) with periorbital cellulitis had sinusitis.

Conclusions: The majority of periorbital and orbital S aureus infections at Texas Children's Hospital were caused by MRSA, and no change was observed over time. Empirical antibiotic treatment should include coverage for MRSA. PVL might be an important virulence factor in these presentations. S aureus is associated with sinusitis and its complications.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jpids/pix036DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
August 2018
34 Reads

Publication Analysis

Top Keywords

orbital cellulitis
32
periorbital orbital
20
days range
16
patients orbital
16
cellulitis
10
orbital
9
antibiotic treatment
8
days received
8
median days
8
children's hospital
8
texas children's
8
cellulitis hospitalized
8
hospitalized median
8
antibiotics days
8
days
8
periorbital cellulitis
8
received antibiotics
8
patients periorbital
8
staphylococcus aureus
8
children periorbital
8

References

(Supplied by CrossRef)
Ocular infectious diseases
Hussein et al.
2014
Periorbital and orbital infections
Wald et al.
2012
Staphylococcus aureus sinus infections in children
Whitby et al.
Int J Pediatr Otorhinolaryngol 2011
Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination
Ambati et al.
Ophthalmology 2000
Microbiology and antibiotic management of orbital cellulitis
Seltz et al.
Pediatrics 2011
Current treatment and outcome in orbital cellulitis
Ferguson et al.
Aust N Z J Ophthalmol 1999
Methicillin-resistant S. aureus infections among patients in the emergency department
Moran et al.
N Engl J Med 2006
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections
Kaplan et al.
Pediatr Infect Dis J 2005
Three-year surveillance of community-acquired Staphylococcus aureus infections in children
Kaplan et al.
Clin Infect Dis 2005
Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas
Mishaan et al.
Pediatr Infect Dis J 2005
Community-associated meticillin-resistant Staphylococcus aureus infections: epidemiology, recognition and management
Patel et al.
Drugs 2009

Similar Publications